Barely Significant
← all excerpts

Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib.

Pharm Sci Adv · 2026 · PMC13234246 · PMID 42256552

Europe PMCDOI
1
hedged sentence
0.0080
closest p · 0.2× alpha
0.0080
boldest claim

The sentences

highly significantP = 0.008actually significant
There was a highly significant ( P = 0.008) improvement in survival on day 180 in the day 1–3 plus day 31–45 treatment groups (60% versus 10% in the control group).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.